Literature DB >> 9488420

Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation.

A Vecchiarelli1, C Retini, C Monari, A Casadevall.   

Abstract

Addition of a monoclonal antibody which binds the Cryptococcus neoformans capsule to suspensions of human monocytes, T lymphocytes, and cryptococcal cells (i) enhances interleukin-1beta (IL-1beta), tumor necrosis factor alpha, and IL-2 production; (ii) reduces IL-10 secretion; and (iii) promotes T-cell proliferation. The ability of specific antibody to influence cytokine production and lymphoproliferation suggests a mechanism by which humoral immunity can influence cell-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9488420      PMCID: PMC108040          DOI: 10.1128/IAI.66.3.1244-1247.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 2.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

3.  Serum therapy for Cryptococcal meningitis.

Authors:  M A Gordon; A Casadevall
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

4.  Formation of histiocyte rings in response to Cryptococcus neoformans infection.

Authors:  S Schneerson-Porat; A Shahar; M Aronson
Journal:  J Reticuloendothel Soc       Date:  1965-09

5.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Authors:  M Feldmesser; A Casadevall
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

6.  Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody.

Authors:  D L Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.

Authors:  S C Lee; A Casadevall; D W Dickson
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

8.  Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.

Authors:  D Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages.

Authors:  A Vecchiarelli; D Pietrella; M Dottorini; C Monari; C Retini; T Todisco; F Bistoni
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

10.  Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes.

Authors:  A Vecchiarelli; C Retini; D Pietrella; C Monari; C Tascini; T Beccari; T R Kozel
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

View more
  11 in total

Review 1.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

2.  A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival.

Authors:  R Teitelbaum; A Glatman-Freedman; B Chen; J B Robbins; E Unanue; A Casadevall; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  An opsonizing monoclonal antibody that recognizes a noncapsular epitope expressed on Cryptococcus neoformans.

Authors:  G J Merkel; B A Scofield
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Antibody interactions with the capsule of Cryptococcus neoformans.

Authors:  M Feldmesser; J Rivera; Y Kress; T R Kozel; A Casadevall
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3.

Authors:  Scott Shapiro; David O Beenhouwer; Marta Feldmesser; Carlos Taborda; Michael C Carroll; Arturo Casadevall; Matthew D Scharff
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

6.  Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.

Authors:  Anna Vecchiarelli; Donatella Pietrella; Francesco Bistoni; Thomas R Kozel; Arturo Casadevall
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

7.  Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses.

Authors:  Marta Feldmesser; Aron Mednick; Arturo Casadevall
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans.

Authors:  C Monari; T R Kozel; A Casadevall; D Pietrella; B Palazzetti; A Vecchiarelli
Journal:  Immunology       Date:  1999-09       Impact factor: 7.397

9.  Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage.

Authors:  Magdia De Jesus; André Moraes Nicola; Susana Frases; Ian R Lee; Steven Mieses; Arturo Casadevall
Journal:  J Immunol       Date:  2009-08-14       Impact factor: 5.422

10.  Cytokine and inducible nitric oxide synthase mRNA expression during experimental murine cryptococcal meningoencephalitis.

Authors:  Claudia M L Maffei; Laurence F Mirels; Raymond A Sobel; Karl V Clemons; David A Stevens
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.